Tumor lysis syndrome after the administration of corticosteroids in an adolescent without confirmed neoplastic disease. Case Reports

Sociedad Argentina de Pediatría..

Tumor lysis syndrome is a potentially lethal complication and constitutes with infections the most frequent oncological emergency. In children, this condition can be secondary to neoplastic diseases, with corticosteroids being a triggering factor. This paper presents the case of an adolescent patient, without known or obvious neoplasms, who developed a tumor lysis syndrome after the administration of corticosteroids due to suspected respiratory infection. The clinical presentation and differential diagnoses are discussed. Special focus is placed on the administration of corticosteroids in clinical conditions with weak scientific evidence. The use of systemic corticosteroids in acute respiratory infections should be evaluated in the clinical context and only indicated in situations with proven effectiveness.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:120

Enthalten in:

Archivos argentinos de pediatria - 120(2022), 1 vom: 02. Feb., Seite e49-e53

Sprache:

Spanisch

Weiterer Titel:

Síndrome de lisis tumoral secundario a la administración de corticoides en una adolescente sin enfermedad neoplásica confirmada: reporte de un caso

Beteiligte Personen:

Ripeau, Diego [VerfasserIn]
Ibarra, Mariano E [VerfasserIn]
Moreno, Rodolfo P [VerfasserIn]
Valentini, Lucila [VerfasserIn]
Hernández, Alberto [VerfasserIn]
Faín, Javier [VerfasserIn]
Seligra, Cecilia [VerfasserIn]
Tevez Echazú, Agustina [VerfasserIn]
Picón, Armando [VerfasserIn]
Cardigni, Gustavo [VerfasserIn]

Links:

Volltext

Themen:

Adrenal Cortex Hormones
Case Reports
Child
Corticosteroids
Pediatrics
Tumor lysis syndrome

Anmerkungen:

Date Completed 10.03.2022

Date Revised 11.03.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.5546/aap.2022.e49

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM336026900